ATE124626T1 - Verwendung von triclosan zur behandlung von krankheiten des gastrointestinaltraktes. - Google Patents

Verwendung von triclosan zur behandlung von krankheiten des gastrointestinaltraktes.

Info

Publication number: ATE124626T1
Authority: AT; Austria
Prior art keywords: triclosan; medicaments; gastrointestinal tract; treating diseases; spheroids
Prior art date: 1990-05-03

Application number

AT91303929T

Other languages

English (en)

Inventor

Peter William Dettmar

John Gareth Lloyd-Jones

Original Assignee

Reckitt & Colmann Prod Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-05-03

Filing date

1991-05-01

Publication date

1995-07-15

1991-05-01 Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd

1995-07-15 Application granted granted Critical

1995-07-15 Publication of ATE124626T1 publication Critical patent/ATE124626T1/de

Links

XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 title abstract 3
229960003500 triclosan Drugs 0.000 title abstract 3
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
210000001035 gastrointestinal tract Anatomy 0.000 title 1
239000003814 drug Substances 0.000 abstract 3
239000007788 liquid Substances 0.000 abstract 2
208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
206010019375 Helicobacter infections Diseases 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
150000001734 carboxylic acid salts Chemical class 0.000 abstract 1
239000007931 coated granule Substances 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
230000002496 gastric effect Effects 0.000 abstract 1
239000008187 granular material Substances 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

AT91303929T 1990-05-03 1991-05-01 Verwendung von triclosan zur behandlung von krankheiten des gastrointestinaltraktes. ATE124626T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909010039A GB9010039D0 (en)	1990-05-03	1990-05-03	Medicament preparation

Publications (1)

Publication Number	Publication Date
ATE124626T1 true ATE124626T1 (de)	1995-07-15

Family

ID=10675466

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91303929T ATE124626T1 (de)	1990-05-03	1991-05-01	Verwendung von triclosan zur behandlung von krankheiten des gastrointestinaltraktes.

Country Status (11)

Country	Link
US (1)	US5286492A (de)
EP (1)	EP0455475B1 (de)
AT (1)	ATE124626T1 (de)
AU (1)	AU645555B2 (de)
CA (1)	CA2041400C (de)
DE (1)	DE69110969T2 (de)
DK (1)	DK0455475T3 (de)
GB (2)	GB9010039D0 (de)
IE (1)	IE65826B1 (de)
NZ (1)	NZ237904A (de)
ZA (1)	ZA912933B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6440395B1 (en)	1992-06-22	2002-08-27	Barry M. Libin	Antiplaque mouth rinse
SE9201930D0 (sv) *	1992-06-24	1992-06-24	Astra Ab	Gastric antibacterial treatment
WO1994026258A1 (en) *	1993-05-13	1994-11-24	Unilever N.V.	Oral compositions containing triclosan for the treatment of aphthous ulcers
WO1995008332A1 (en) *	1993-09-20	1995-03-30	The Procter & Gamble Company	Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
US6902738B2 (en) *	1994-05-02	2005-06-07	Josman Laboratories, Inc.	Topical oral dosage forms containing bismuth compounds
US6426085B1 (en)	1994-05-02	2002-07-30	Josman Laboratories Inc.	Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en)	1994-05-02	1998-11-10	Josman Laboratories, Inc.	Chewing gum containing colloidal bismuth subcitrate
AU6580494A (en) *	1994-05-11	1995-12-05	P.N. Gerolymatos S.A.	Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases
US5498528A (en) *	1994-06-10	1996-03-12	King; Wing	Detection of helicobacter pylori
GB9505032D0 (en)	1995-03-13	1995-05-03	Westminster Lab Ltd	Improvements in or relating to organic compositions
CA2193104A1 (en) *	1994-06-29	1996-01-11	Peter William Dettmar	Pharmaceutical compositions containing triclosan or derivatives thereof and edta or egta
US5389386A (en) *	1994-06-30	1995-02-14	Church & Dwight Co., Inc.	Method of controlling fungal disease in cultivated plants
US6379651B1 (en)	1995-02-07	2002-04-30	Josman Laboratories	Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en)	1995-02-07	2002-04-16	Josman Laboratories, Inc.	Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
WO1997045103A1 (en) *	1996-05-31	1997-12-04	R & D Ventures, Inc.	Effervescent bath tablet compositions
PT959888E (pt) *	1996-08-13	2002-02-28	Gerolymatos P N Sa	Utilizacao do agente quelante clioquinol para o fabrico de uma composicao farmaceutica para o tratamento de doenca de alzheimer
GB9708772D0 (en) *	1997-04-30	1997-06-25	Reckitt & Colmann Prod Ltd	Organic compositions
PL194696B1 (pl) *	1997-04-30	2007-06-29	Reckitt Benckiser Healthcare	Kompozycja w stałej postaci dawkowania zawierająca alginiany
US6108850A (en) *	1997-06-03	2000-08-29	Mclaughlin; Gerald	Accelerated method and instrumentation for whitening teeth
US5980914A (en) *	1997-08-22	1999-11-09	P.N. Gerolymatos S.A.	Clioquinol for the treatment of Parkinson's disease
US5994323A (en) *	1997-12-31	1999-11-30	P.N. Gerolymatos S.A.	Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof
GB9809347D0 (en) *	1998-05-05	1998-07-01	Reckitt & Colmann Prod Ltd	Compositions
DK0976395T3 (da) *	1998-07-30	2005-11-14	Merck Sante Sas	Tablet til langvarig afgivelse af et lægemiddel i maven
US5945089A (en) *	1998-11-05	1999-08-31	I-Dent International Corporation	Method of treating mucositis
IN190017B (de) *	1999-01-25	2003-05-31	Panacea Biotech Ltd
US6576625B2 (en)	2001-03-16	2003-06-10	Panacea Biotic Limited	Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
KR100753471B1 (ko) *	2001-09-06	2007-08-31	주식회사 엘지생활건강	트리클로산을 포함하는 마이크로 캡슐의 제조방법
GB2384986B (en) *	2002-02-12	2004-01-07	Reckitt Benckiser Healthcare	Compositions for the treatment of disorders of the upper gastrointestinal tract
WO2003074086A1 (fr) *	2002-03-04	2003-09-12	Medrx Co., Ltd.	Matrice liquide a transfert de phase in vivo, et preparations liquides orales
AU2003304197A1 (en) *	2003-06-18	2005-01-04	N.V. Nutricia	Hot liquid fiber product
US20070178150A1 (en) *	2003-07-10	2007-08-02	Prasad Adusumilli	Pharmaceutical compositions
WO2005018613A1 (de) *	2003-08-26	2005-03-03	Mandapro Ag	Pellets für die orale applikation von pharmazeutischen wirkstoffen
US20060252831A1 (en) *	2005-05-06	2006-11-09	Christopher Offen	Method for the treatment of magnesium and potassium deficiencies
US20060252830A1 (en) *	2005-05-06	2006-11-09	Brandon Stephen F	Method for the treatment of magnesium and potassium deficiencies
GB0515492D0 (en) *	2005-07-28	2005-08-31	Reckitt Benckiser Healthcare	Improvements in or relating to compositions,articles and methods
ATE545341T1 (de) *	2005-10-05	2012-03-15	Fmc Biopolymer As	Gelierungszusammensetzungen und -verfahren
DE102006062111A1 (de)	2006-12-23	2008-06-26	Farco-Pharma Gmbh	Zusammensetzung, insbesondere für das Blockieren von Kathetern
EP4051772A1 (de) *	2019-10-31	2022-09-07	The Procter & Gamble Company	Antimikrobielle partikel

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH406127A (de) *	1963-02-22	1966-08-15	Geigy Ag J R	Verfahren zum antimikrobiellen Ausrüsten von Textilien
JPS5157813A (en) *	1974-11-14	1976-05-20	Sankyo Co	Ll dooba mataha sonojudotaiseizaino seiho
GB2015875B (en) *	1978-02-24	1982-10-20	Novex Foreign Trade Co Ltd	Solid oral pharaceutical product with increased efficacy and predetermined steady state of solubility
WO1986005981A1 (en) *	1985-04-18	1986-10-23	Borody Thomas J	Treatment of non-ulcer dyspepsia with bismuth salts
GB8514665D0 (en) *	1985-06-11	1985-07-10	Eroceltique Sa	Oral pharmaceutical composition
ATE79261T1 (de) *	1985-06-13	1992-08-15	Barry James M D Marshall	Verfahren zur behandlung von magen-darmstoerungen.
DE3650504T2 (de) *	1985-06-13	1996-10-31	Marshall Barry James	Verfahren und Zusammensetzungen zur Behandlung von gastrointestinalen Störungen
GB8526093D0 (en) *	1985-10-22	1985-11-27	Beecham Group Plc	Composition
US4959384A (en) *	1985-10-24	1990-09-25	Norwich Eaton Pharmaceuticals, Inc.	Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
IL85472A (en) *	1987-03-09	1991-06-30	Procter & Gamble	Pharmaceutical compositions for treating gastrointestinal disorders
DE3874917T2 (de) *	1987-03-09	1993-03-04	Procter & Gamble	Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
JP2733849B2 (ja) *	1987-10-12	1998-03-30	ボロディー，ソーマス・ユリウス	胃腸障害治療のための改良された方法

1990
- 1990-05-03 GB GB909010039A patent/GB9010039D0/en active Pending
1991
- 1991-04-19 ZA ZA912933A patent/ZA912933B/xx unknown
- 1991-04-22 NZ NZ237904A patent/NZ237904A/xx unknown
- 1991-04-26 AU AU75968/91A patent/AU645555B2/en not_active Ceased
- 1991-04-29 CA CA002041400A patent/CA2041400C/en not_active Expired - Fee Related
- 1991-04-30 US US07/693,598 patent/US5286492A/en not_active Expired - Lifetime
- 1991-05-01 AT AT91303929T patent/ATE124626T1/de not_active IP Right Cessation
- 1991-05-01 DE DE69110969T patent/DE69110969T2/de not_active Expired - Fee Related
- 1991-05-01 DK DK91303929.3T patent/DK0455475T3/da active
- 1991-05-01 GB GB9109439A patent/GB2243549B/en not_active Expired - Fee Related
- 1991-05-01 EP EP91303929A patent/EP0455475B1/de not_active Expired - Lifetime
- 1991-05-02 IE IE148391A patent/IE65826B1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0455475A3 (en)	1992-02-26
EP0455475B1 (de)	1995-07-05
CA2041400C (en)	2001-04-24
HK1007963A1 (en)	1999-04-30
IE65826B1 (en)	1995-11-15
US5286492A (en)	1994-02-15
DE69110969T2 (de)	1995-11-16
GB2243549B (en)	1994-05-04
AU7596891A (en)	1991-11-07
ZA912933B (en)	1992-01-29
GB9010039D0 (en)	1990-06-27
EP0455475A2 (de)	1991-11-06
IE911483A1 (en)	1991-11-06
GB9109439D0 (en)	1991-06-26
GB2243549A (en)	1991-11-06
NZ237904A (en)	1993-06-25
CA2041400A1 (en)	1991-11-04
DE69110969D1 (de)	1995-08-10
DK0455475T3 (da)	1995-10-30
AU645555B2 (en)	1994-01-20

Legal Events

Date	Code	Title	Description
1996-01-15	UEP	Publication of translation of european patent specification
2002-02-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69110969D1 (de)	1995-08-10	Verwendung von Triclosan zur Behandlung von Krankheiten des Gastrointestinaltraktes.
ATE108657T1 (de)	1994-08-15	Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
NZ221805A (en)	1991-02-26	Oral, solid, controlled release pharmaceutical dosage form; preparatory processes
CA1134745A (en)	1982-11-02	Pharmaceutical preparations
NO2011009I1 (no)	2011-06-20	Naproksen- og esomeprazoltabletter med modifisert frisetting
AR028299A1 (es)	2003-05-07	Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
IL110190A (en)	2000-07-26	Magnesium omeprazole with crystallinity higher than 70% process for its preparation and its use in the manufacture of medicaments for inhibiting gastric acid secretion and for obtaining gastric mucosa protective activity
DE3766343D1 (de)	1991-01-03	Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel.
ATE141511T1 (de)	1996-09-15	Verwendung eines bakteriozin antibiotischen agenten zur herstellung eines arzneimittels zur behandlung von magenverstimmungen, die durch helicobacter pylori verursacht werden.
RU93036959A (ru)	1996-05-20	Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
BG105173A (en)	2001-11-30	Novel salt form of pantoprazole
TR200001810A3 (tr)	2001-11-21	Hemen Eriyen Oral Dozaj Formülasyonu.
EP0425298A3 (en)	1991-09-11	Sustained-release preparation of basic medical agent hydrochloride
IL85963A0 (en)	1988-09-30	Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
GB9205670D0 (en)	1992-04-29	New derivatives of physostigmine,their use and pharmaceutical formulations containing them
EP0383481A3 (de)	1991-04-10	Bukkale Anästhetika
DE2960927D1 (en)	1981-12-17	N1-benzoyl-n2-phenyl-1,3-diaminopropane-2-ols and their salts, process for their preparation and medicaments containing them
JPS5942318A (ja)	1984-03-08	製薬組成物、その製造法及び応用
JPH07501076A (ja)	1995-02-02	次サリチル酸ビスマスの単位剤形
JP4102461B2 (ja)	2008-06-18	解熱剤
JPS5517329A (en)	1980-02-06	Remedy for dementia and dotage
RU96123569A (ru)	1999-01-27	Лекарственный препарат
JPS57114518A (en)	1982-07-16	Hypotensive agent
JPS5634624A (en)	1981-04-06	Central nervous system depressant
RU2001112155A (ru)	2003-02-27	Лекарственный препарат